Helicobacter pylori mediated Gastritis, Peptic Ulcer and Gastric Cancer
Abstract
Full Text:
PDFReferences
http://www.cancerresearchuk.org/cancer-info/cancerstats/
Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012; 13(6): 607–15p.
http://www.cancer.org/cancer/stomachcancer/detailedguide/stomach-cancer-
key-statistics.
http://www.cdc.gov/ulcer/files/hpfacts.pdf
Dent JC, McNulty CAM. Evaluation of a new selective medium for Campylobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 1988, 7: 555–68p.
Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49(3): 347–53p.
http://www.worldgastroenterology.org/helicobacter-pylori-in-developing-countries.html
Al-Sulami AA, Al-Taee AMR, Juma’a MG. Isolation and identification of Helicobacter pylori from drinking water in Basra governorate. Iraq East Mediterr Health J. 2010; 16(9): 920–5p.
http://www.merckmanuals.com/professional/gastrointestinal_disorders/gastritis_and_peptic_ulcer_disease/helicobacter_pylori_infection.html
Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annual Review of Pathology. 2006; 1:63–96p.
Kusters JG. van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews. 2006; 19(3): 449–90p.
Rafeey M, Ghotaslou R, Milani M, et al. Association between Helicobacter pylori, cagA, and vacA Status and Clinical Presentation in Iranian Children. Iran J Pediatr. 2013; 23(5): 551–56p.
Hosseini E, Poursina F, de Wiele TV, et al. Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci. 2012; 17(3): 280–92p.
Contreras M, Abrante L, Salazar V, et al. Heterogeneity of cag genotypes of Helicobacter pylori in the esophageal mucosa of dyspeptic patients and its relation to histopathological outcomes. Int J Infect Dis. 2014; 26: 91–5p.
1Memon AA, Hussein NR, Miendje Deyi VY, et al. Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: a matched case-control study. J Clin Microbiol. 2014; 52(8): 2984–9p.
Pereira W. N, Ferraz MA, Zabaglia L. M. et al. Association among H. pylori virulence markers dupA, cagA and vacA in Brazilian patients. J Venom Anim Toxins Incl Trop Dis. 2014; 20(1): 1p.
Wang M. Y, Chen C, Gao X. Z, et al. Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in a region at high risk of gastric cancer. Microb Pathog. 2013; 59–60:13–8p.
Karabiber H, Selimoglu M.A, Otlu B, et al. Virulence factors and antibiotic resistance in children with Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr. 2014; 58(5): 608–12p.
Johannes G.K, van Vliet Arnoud H. M., Ernst J. K.Pathogenesis of Helicobacter pylori Infection Clin Microbiol Rev. 2006 Jul; 19(3): 449–90p.
Pandya HB, Patel JS, Agravat HH, et al.Noninvasive Diagnosis of Helicobacter pylori: Evaluation of Two Enzyme Immunoassays, Testing Serum IgG and IgA Response in the Anand District of Central Gujarat,India. J Clin Diagn Res. 2014; 8(6): DC12–5p.
Rasheed F, Khalid A, Saadia A, et al. Correlation of 13C urea breath test values with Helicobacter pylori load among positive patients. Hepatogastroenterology. 2014 Jan-Feb; 61(129):125–8p.
Patel SK, Pratap CB, Jain AK, et al. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol. 2014; 20(36): 12847–59p.
http://www.mayoclinic.org/diseases-conditions/h-pylori/basics/treatment/con-20028643.
Song Z, Zhang J, He L, et al. Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients. Dig Liver Dis. 2014; 46(12): 1077–81.
Yang T, Li H, Chen J, et al. Epidemiological study on antibiotic resistance among Helicobacter pylori in Taizhou district, Zhejiang, 2010–2013. Zhonghua Liu Xing Bing Xue Za Zhi. 2014; 35(6): 704–7p.
Karczewska E, Klesiewicz K, Wojtas-Bonior I, et al. Levofloxacin resistance of Helicobacter pylori strains isolated from patients in southern Poland, between 2006–2012. Acta Pol Pharm. 2014; 71(3): 477–83p.
Boyanova L, Davidkov L, Gergova G, et al. Helicobacter pylori susceptibility to fosfomycin, rifampin, and 5 usual antibiotics for H. pylori eradication. Diagn Microbiol Infect Dis. 2014; 79(3): 358–61p.
DOI: https://doi.org/10.37628/ijbb.v1i1-2.19
Refbacks
- There are currently no refbacks.